We are live on
!
Find out more
United Therapeutics
UTHR
UTHR
506 hedge funds and large institutions have $10.1B invested in United Therapeutics in 2023 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 184 increasing their positions, 166 reducing their positions, and 87 closing their positions.
New
Increased
Maintained
Reduced
Closed
11% more repeat investments, than reductions
Existing positions increased: 184 | Existing positions reduced: 166
0.26% more ownership
Funds ownership: 98.39% → 98.65% (+0.26%)
3% less first-time investments, than exits
New positions opened: 84 | Existing positions closed: 87
6% less call options, than puts
Call options by funds: $40.2M | Put options by funds: $42.6M
1% less funds holding
Funds holding: 512 → 506 (-6)
18% less capital invested
Capital invested by funds: $12.3B → $10.1B (-$2.19B)
26% less funds holding in top 10
Funds holding in top 10: 23 → 17 (-6)
Holders
506
Holders Change
-6
Holders Change %
-1.17%
% of All Funds
8.06%
Holding in Top 10
17
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-26.09%
% of All Funds
0.27%
New
84
Increased
184
Reduced
166
Closed
87
Calls
$40.2M
Puts
$42.6M
Net Calls
-$2.42M
Net Calls Change
-$9.23M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$299M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
+$118M |
| 3 |
State Street
Boston,
Massachusetts
|
+$60.6M |
| 4 |
BlackRock
New York
|
+$59.6M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$51.4M |
Top Sellers
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$218M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$66.8M |
| 3 |
Millennium Management
New York
|
-$61.7M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$52.6M |
| 5 |
FAM
Fred Alger Management
New York
|
-$45.2M |
